Latterell Venture Partners
Latterell Venture Partners (LVP) invests in early stage biotechnology, specialty pharmaceutical, and medical device companies with innovative technologies, large market opportunities, and passionate entrepreneurs. The LVP General Partners offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable entrepreneurs to create highly successful new start-ups. Over the past twenty years, the LVP team has built more than thirty successful biomedical companies. Among these are medical device companies such as Pathway, Cardiomind, and Xtent; and biotech companies such as OncoMed and also Proteolix, where LVP was the founding investor. More information about LVP is available at www.lvpcapital.com.
VantagePoint Capital Partners
VantagePoint Venture Partners is a leader in investing in 21st Century technologies and partners with entrepreneurs in the CleanTech, Healthcare, and Information Technology sectors. With a large investment team of experts, a broad network of strategic partners and advisors, and more than $4.5 billion in committed capital, VantagePoint has the depth of resources to help build transformative companies that are clear leaders in their categories. The Silicon Valley firm has investments in more than 70 companies including TargeGen, Anthera, Conceptus, WageWorks, Better Place, BrightSource Energy, Mascoma, Miasole, ReachLocal and others. For more information visit www.vpcp.com.